airway remodelling observed in patients with asthma, as longer periods of allergen exposure are required to mimic these changes [4, 5] . The pathophysiology of airway remodelling remains largely unknown, but the structural alterations in the airway are thought to result from (inadequate) attempts at tissue repair in response to inflammation [6] . In addition, it is currently unclear to what extent this process contributes to the deterioration of asthma symptoms [7] or represents the translation of a repair response that protects against further allergeninduced airway inflammation and bronchoconstriction [8] . The pattern of these structural changes differs between mouse strains [9] , suggesting the genetic background might be important. Whether remodelling develops uniformly in all asthma patients is equally unclear [10] .
Remarkably, prolonged challenge with inhaled allergen in sensitized mice is often associated with disappearance of eosinophilic airway inflammation and the induction of a state of respiratory tolerance [11] [12] [13] [14] . While the immunological mechanisms behind this phenomenon are still poorly understood, tolerance appears to develop in most models using chronic allergen challenge [9, 14] .
Although a wide variety of mouse asthma models exist [3, 9, 15, 16] , it remains puzzling how airway inflammation, remodelling and responsiveness relate to each other in these models. Thus, we here aimed to provide a thorough characterisation encompassing an assessment of inflammation, airway (hyper)responsiveness (AHR) and the remodelling features seen in the 2 mouse strains most commonly used in the study of asthma, C57BL/6 and BALB/c. We provide this comparative analysis in order to gain insight into the relationship between these asthma characteristics in both strains. We found that upon shortterm challenge, the strains developed differential responses in inflammation, AHR and airway remodelling, particularly airway smooth muscle (ASM) proliferation. Upon prolonged exposure, the strains developed more similar structural airway alterations that paralleled a disappearance of eosinophilic inflammation and AHR.
Materials and Methods
Animals C57BL/6 and BALB/c mice (all males, 6-8 weeks old) were purchased from Harlan (Zeist, The Netherlands). All experimental procedures were approved by the local ethics committee for animal experiments (Faculty of Medicine and Health Sciences, Ghent University).
Allergen Exposure Protocols
All groups of mice (6-12 mice/group) were sensitized with 10 g intraperitoneal (i.p.) ovalbumin (OVA; Grade III; Sigma, St. Louis, Mo., USA) adsorbed to 1 mg Al(OH) 3 on days 0 and 7. From day 14 onward, the mice were exposed to aerosolized (Ultraschallvernebler Sirius Nova, Heyer Medizintechnologie, Bad Ems, Germany) OVA (1% wt/v) or PBS 30 min/day, 3 times a week for 2 ('acute'), 6 or 9 ('chronic') weeks ( fig. 1 ).
Bronchoalveolar Lavage Fluid: Cellular Analysis
Twenty-four hours after the last aerosol exposure, mice were sacrificed with an i.p. pentobarbital injection (60 mg/kg; Sanofi, Libourne, France). Briefly, bronchoalveolar lavage fluid (BALF) was taken by instillation of Hanks' balanced salt solution via a tracheal cannula. Three lavages with 0.3 ml Hanks' solution followed by 3 lavages with 1 ml Hanks' solution were performed. The recovered BALF from the first 3 fractions was centrifuged and the supernatant was used for cytokine detection. The cell pellet was then added to the rest of the lavage fluid, centrifuged, subjected to red blood cell lysis and resuspended for cell counts on cytospins (May-Grünwald/Giemsa). OVA and adjuvant i.p. Fig. 1 . Allergen exposure protocols. Sensitized C57BL/6 and BALB/c mice were exposed to OVA aerosols. a Protocol A: mice exposed for 2 weeks. b Protocol B: mice exposed for 6 weeks. c Protocol C: mice exposed for 9 weeks.
Histology
After fixation of the left lung with 4% paraformaldehyde, slices from all left lobes were embedded in paraffin for histological analysis. Sections of 3 m were stained with Congo Red to highlight eosinophils, Periodic-Acid Schiff (PAS) to highlight goblet cells and with Sirius Red for collagen staining.
Immunohistochemistry
Immunohistochemistry (IHC) for fibronectin was done in an analogous manner to that previously described in the rat [17] . Briefly, lung sections of 3 m were deparaffinized, rehydrated and the nonspecific binding sites were blocked with 1% blocking reagent in PBS (Boehringer, Mannheim, Germany). Excess reagent was removed and the sections were incubated for 1 h with a mouse anti-mouse fibronectin antibody (dilution factor 1/750; Dako A/S, Glostrup, Denmark). Afterwards, sections were rinsed and incubated with a biotinylated secondary antibody for 30 min. Next, the primary antibody-secondary antibody complex was detected by streptavidin-biotinylated horseradish peroxidase complex. The substrate for the peroxidase was 3, 3 -diaminobenzidine (DAB; Dako), resulting in a brown reaction product for fibronectin quantification. IHC for ␣ -actin smooth muscle contractile elements in the airways (ASM) was performed in an analogous manner, using an anti-mouse ␣ -actin SM antibody (dilution factor 1/100; Dako) and DAB substrate, also resulting in a brown reaction product.
Quantitative Measurements in the Airway Wall
Quantitative measurements were performed in the airways of each animal with a perimeter of basement membrane (Pbm) ranging from 800 to 2,000 m, provided a reasonable cross section was available (ratio of maximal to minimal internal diameter ! 1.8). Measurements were performed on the digital representation of the airways using a Zeiss KS400 image analyser system (Oberkochen, Germany), as described earlier [17] . Morphometrical parameters were marked manually: the area defined by the basement membrane (Abm) and the area defined by the total adventitial perimeter (Ao). The total bronchial wall area (WAt) was calculated (WAt = Ao -Abm) and normalized to the square of the Pbm. For the quantification of collagen deposition, the area in the airway wall covered by the Sirius Red stain (WCt) was determined by the software and normalized to Pbm. To evaluate the subepithelial fibronectin deposition and the ASM content of the airways, the area covered by the DAB stain (WFt and W ␣ A) was determined in an analogous manner and also normalized to Pbm. Goblet cells were quantified on PAS stained sections. Results were expressed as the number of goblet cells per millimeter of basement membrane. Peribronchial infiltration with eosinophils was evaluated in lung sections stained with Congo Red and the total number of eosinophils per mm 2 of bronchial wall was determined. All measurements were performed on 5 airways per mouse.
IgE and Protein Quantification (ELISA)
OVA-IgE in serum was measured with ELISA using coated microtiter plates and biotinylated polyclonal rabbit anti-mouse IgE (S. Florquin, Université Libre de Bruxelles, Brussels, Belgium). OVA-specific IgE are expressed in arbitrary units (U) per ml serum (an OVA-IgE U). One OVA-IgE U was defined as a 1: 100 dilution of an internal standard serum pool obtained from mice sensitized with OVA (10 g)/alum (1 mg). TGF-␤ 1 was determined in the bronchoalveolar lavage fluid (BALF) using ELISA kits (R&D Systems, Abingdon, UK).
Assessment of Airway Responsiveness
Twenty-four hours after the last aerosol exposure, AHR to methacholine was assessed in spontaneously breathing animals using a whole body plethysmograph system (Buxco, Buxco Electronics Inc., Troy, N.Y., USA). Before performing readings, the system was calibrated by rapid injection of 1 ml air. Pressure differences between the main chamber containing mice and a reference chamber were recorded using the software BioSystem XA (version 157, Buxco). This pressure signal is caused by flow changes in the main box during the respiratory cycle of the animal. The value of 'enhanced pause' (Penh) is used here to monitor airway function [18] , since it shows strong correlation with the airway resistance [19] . Penh = [(Te -Tr)/Tr] ! (PEP/PIP), where Te is expiratory time (in seconds), Tr is relaxation time or time of the pressure decay to 36% of total box pressure during expiration, PEP is peak expiratory pressure (in cm H 2 O) and PIP is peak inspiratory pressure (in cm H 2 O). For each mouse, data were recorded at baseline, and after exposure to PBS or increasing concentrations of nebulized methacholine (2-81 mg/ml), to assess AHR. The solutions were nebulized through an inlet of the main chamber during 1 min. Readings were taken during 5 min after each nebulization. Between readings, the Penh value returned to baseline. Cumulative dose-response curves were constructed for the changes in Penh after increasing doses of methacholine. The changes in Penh are expressed as percentage increase of maximum Penh value following methacholine challenge compared to the average Penh value after PBS exposure (calculated by Analyst 1.29, Buxco).
Statistical Analysis
Data were analysed with the statistical package SPSS 15.0 (SPSS Inc., Chicago, Ill., USA). Reported values are expressed as mean 8 standard error of the mean. Mean values of parameters (including quantitative measurements in the airway wall as well as inflammatory cells and mediators, but not Penh values) were compared between the groups through the Kruskall-Wallis test for multiple comparisons (nonparametric testing). When significant differences were observed, post-hoc comparisons between groups were made, using the Mann-Whitney U test with Bonferroni corrections. p ! 0.05 was considered significant. The doseresponse curves of Penh were compared using ANOVA. The concentration of methacholine causing a 250% increase in baseline Penh was calculated by log-linear interpolation of the dose-response curve.
Results

Airway Inflammation in the BALF and Bronchial Walls
OVA exposure for 2 weeks ( fig. 1 a) . Only C57BL/6 mice had a discrete but significant concomitant BALF neutrophilia and a significant increase in total BALF cellularity and macrophages. Moreover, both strains developed peribronchial and perivascular eosinophilic inflammation upon short-term challenge ( fig. 3 a,  b ). C57BL/6 mice, but not BALB/c mice also possessed some degree of interstitial inflammation ( fig. 3 c, d ).
The numbers of eosinophils counted around the airways on Congo Red stained sections were significantly higher in the C57BL/6 strain compared to the BALB/c strain ( table 1 ) .
Upon longer OVA exposure (6 or 9 weeks; fig. 1 b, c) the BALF cell composition in OVA-challenged mice of both strains returned to the composition discerned in mice exposed to PBS ( fig. 2 ). At those points in time, only a slightly elevated number of eosinophils remained present in the bronchial walls of both mouse strains ( table 1 ).
Serum OVA-IgE
Whereas the PBS-challenged C57BL/6 mice had very low OVA-IgE levels at all points in time, the BALB/c counterparts developed increasing IgE levels attributable uniquely to the i.p. sensitization ( table 2 ). In the OVAchallenged mice of both strains, OVA-IgE had already in- creased after 2 weeks as compared to their PBS-challenged counterparts. Upon chronic exposure, both strains had elevated IgE; however, the titres were markedly higher in the BALB/c mice as compared to the C57BL/6 mice (p ! 0.05 BALB/c vs. C57BL/6).
Epithelial Remodelling: Goblet Cells
Exposure to OVA resulted in a significant increase in goblet cells from 2 weeks onward ( fig. 4 a and 5 a) , which was comparable in both strains. This increase persisted after 6 and 9 weeks ( fig. 4 a) . However, in both allergenchallenged C57BL/6 and BALB/c mice, the goblet cells did not increase any further upon prolonged challenge.
Airway Smooth Muscle
The amount of ASM did not change over time in the PBS-exposed mice, either in BALB/c or in C57BL/6 mice ( fig. 4 b and 5 b) . Exposure to OVA allergen for 2 weeks resulted in a significant increase in ASM staining only in BALB/c mice. However, longer allergen exposure periods induced an increase in ASM in both strains. 
Morphometry and Deposition of Extracellular Matrix Proteins
Morphometry WAt or airway wall thickness of large-sized airways did not differ in either strain at 2, 6 or 9 weeks of PBS ( fig. 6 a) . Exposure to OVA allergen for 2 weeks resulted in a significant increase in WAt only in the BALB/c mice when compared to sham-exposed mice. However, longer allergen exposures induced a significant and persistent increase in WAt in both strains.
Fibronectin and Collagen
Fibronectin and collagen deposition were similarly increased in both genotypes after 6 and 9 weeks, respectively ( fig. 5 c, d and 6 b, c) . Histology pictures of the airways of C57BL/6 mice challenged with OVA or PBS aerosols for 2 or 9 weeks. Original magnifications ! 100, an inset with higher magnification is included. All stains were performed in the BALB/c strain as well, leading to analogous results at these points in time. a PAS staining to highlight goblet cells in C57BL/6 mice challenged with OVA or PBS for 2 weeks. b IHC with DAB substrate to highlight the increase in ASM contractile elements (brown colour) in BALB/c mice challenged with OVA or PBS for 9 weeks. c IHC with DAB substrate to highlight fibronectin deposition (brown colour) in C57BL/6 mice challenged with OVA or PBS for 9 weeks. d Sirius Red staining to highlight collagen deposition in C57BL/6 mice challenged with OVA or PBS for 9 weeks. Airway Hyperresponsiveness BALB/c but not C57BL/6 mice developed a significant leftward shift in the dose-response curve to inhaled methacholine after 2 weeks of OVA exposure (ANOVA; p ! 0.005 vs. PBS; figure 7 a, d) . After a longer exposure period (6 or 9 weeks), no difference in the dose-response curve was observed for either strain ( fig. 7 b-c, e-f) . The C57BL/6 mice were less responsive to methacholine than BALB/c mice. At 2 weeks, the concentration of methacholine that caused a 250% increase in Penh from baseline in allergen-exposed C57BL/6 was 17.40 8 5.92 mg/ ml versus 4.69 8 1.81mg/ml in BALB/c mice (p ! 0.05 BALB/c vs. C57BL/6). spiratory tolerance that can develop after prolonged allergen exposure [11] [12] [13] [14] . However, long-term exposure protocols are usually applied to study the main features of airway remodelling [4, 5, 14, 16] . In these models, inflammation and lung function tests are often either absent or partially described [4, 5, 20] . We chose to provide here a comprehensive analysis encompassing not only the assessment of inflammation and responsiveness, but also a thorough characterisation of remodelling characteristics.
Here, we found that inflammation and remodelling behave differently in both strains, especially in the acute models, based on short-term allergen exposure (2 weeks; fig. 1 a) . Both strains developed eosinophilic inflammation, as evident from BALF analysis and quantification of peribronchial eosinophilia. However, airway eosinophilia was more pronounced in the C57BL/6 mice in the acute model. This is in line with one earlier study, that also found that C57BL/6 mice are more susceptible to the development of airway eosinophilia [21] . In contrast, Shinagawa and Kojima [9] found a more pronounced eosinophilia in BALB/c mice after repeated (chronic) intranasal OVA instillation. We presume the method of antigen exposure is critical in this respect, as we administered OVA 1% by aerosol whereas Shinagawa and Kojima administered OVA 0.1% intranasally. Serum OVA-IgE levels were more elevated in the BALB/c mice than in C57BL/6 after prolonged OVA challenge (6 and 9 weeks; fig. 1 a, b) confirming earlier findings that showed that BALB/c mice are IgE prone [22] . This is also underscored by the fact that BALB/c mice, but not C57BL/6, already have measurable IgE titres after sensitization only.
In the BALB/c mice we could observe a significant increase in ASM after just 2 weeks of OVA challenge ('acute';
BALF Proteins
TGF-␤ 1 levels in BALF were persistently increased after 2 or 9 weeks of allergen exposure compared to control PBS-exposed mice in both strains ( fig. 8 ).
Discussion
We here document that in the 2 mouse strains most commonly used to model asthma (C57BL/6 and BALB/c), genetic background and the duration of allergen exposure have a profound impact on different aspects of the resulting pathological phenotype. Although the acute response in both strains was predominated by eosinophilic airway inflammation, only the BALB/c strain developed a significant ASM hyperplasia and AHR. In an attempt to mimic more closely the features of chronic asthma, the response to longer periods of allergen exposure was predominated by airway remodelling, while inflammation and AHR decreased in both strains. Although other groups have earlier described strain differences in response to various durations of OVA aerosol exposure [9] , the current study gives a more detailed insight into the relationship between inflammation, remodelling and responsiveness in the 2 most commonly used mouse strains.
Inflammation, AHR and airway remodelling are thought to be interdependent processes. A large variety of mouse models focus on a limited number of characteristics of asthma to study the underlying pathogenesis [14, 15] . To study inflammation, these models mainly rely on (hyper-)acute, short-term exposure protocols. The reason for this is that the use of short-term exposure protocols is practical but also avoids the establishment of re- fig. 1 a) , in contrast to the C57BL/6 strain, where longer durations of allergen exposure were required to obtain such an ASM increase. In addition, AHR was present in BALB/c mice at that point in time. This histological observation now adds up to the earlier descriptions that inbred mouse strains exhibit significant genetic variability in the airway calibre and development of AHR after antigen sensitization and exposure [9, 23] . Although the contraction of ASM is the ultimate translation of asthma pathology into physiologic disturbance in patients, it remains an unresolved issue if a larger smooth muscle mass is really the cause of AHR [24, 25] . Some studies indicate a clear link between ASM and AHR in both animal models and humans, since both AHR and increased ASM can persist after resolution of the airway inflammation [26] [27] [28] , and mathematical models predict that airways with increased ASM narrow to a much greater extent than airways with a smaller ASM volume [29] . One could speculate that the lack of AHR after 2 weeks of OVA exposure in C57BL/6 mice could be related to the absence of ASM hyperplasia. However, other factors could be involved. Firstly, the C57BL/6 strain developed a certain degree of interstitial inflammation, which was earlier also reported by another group [30] . Secondly, the airway anatomy of both strains is different [31] . Both of these factors could be of potential relevance to explain why AHR was observed only in the BALB/c strain.
Prolonged allergen challenge ( fig. 1 b, c ) results in increased fibronectin and collagen deposition in the airway wall in both strains which is concordant with findings described by other authors [20, 26, [32] [33] [34] [35] . We here document that this structural remodelling occurs in parallel with a decrease in inflammatory cells in the BALF compartment to baseline in both strains and loss of AHR in BALB/c mice. We and others previously described that prolonged OVA challenge in these mice results in the establishment of respiratory tolerance, as they are unresponsive to new sensitizations [12] . To date, the precise mechanisms of the development of respiratory tolerance in mice repeatedly challenged with OVA aerosols have not been elucidated, and both regulatory T cell-dependent [36] and regulatory T cell-independent [37] mechanisms have been proposed. One factor that may be important in the down-regulation of allergic airway inflammation and AHR over time could be the aging of mice, because some studies found that the capability of T cells to differentiate into Th-2 cells was reduced in aging mice [38, 39] . In contrast, one recent study found that older mice developed increased allergic inflammation, but less pronounced AHR [40] . Moreover, we earlier documented that mice over 20 weeks old can easily develop Th-2-mediated airway inflammation [12] . Thus, the precise effect of aging on allergic airway disease remains a matter of debate [39] [40] [41] .
The exact role of the eosinophils in remodelling, inflammation and AHR is speculative. It is possible that eosinophils could contribute to the initiation of collagen synthesis by fibroblasts during the acute inflammatory phase [42] . In our opinion, the few remaining eosinophils in the bronchial wall upon prolonged allergen exposure represent a small but measurable fraction deemed to vanish shortly thereafter. In BALB/c mice, the decrease of eosinophilic inflammation and increase of fibrosis in the airway wall occurs in parallel with the loss of AHR. It is thus tempting to speculate that the remodelling process could occur in an attempt to protect against allergen-induced AHR and inflammation. Collagen and fibronectin deposition could indeed increase airway wall stiffness and oppose extended narrowing of the airway wall. Moreover, the subepithelial fibrosis could decrease the amount of allergen exposure by shielding the immune system from the allergens ('wash-away' effect).
TGF-␤ 1 is a key molecule involved in the regulation of both inflammation and remodelling in both humans and mouse models [43] [44] [45] [46] , and therefore represents a potential therapeutic target of interest. Increases in TGF-␤ 1 are a constant finding for both mouse strains used here, in the acute and in the chronic exposure models. It could therefore be speculated that TGF-␤ 1 is activated quite early as an endogenous 'anti-asthma' molecule to control inflammation [45, 46] , to promote remodelling [43, 44, 47] and thus to inhibit AHR [48] . However, previous studies using neutralising antibodies for TGF-␤ 1 produced conflicting results on its role. One study found that anti-TGF-␤ 1 antibody treatment could antagonize matrix deposition, smooth muscle cell proliferation and mucus production without affecting the airway inflammation [47] . In contrast, in a recent report based on an intranasal HDM administration it was shown that anti-TGF-␤ 1 treatment did not inhibit remodelling, but rather induced an exacerbation of the allergen-induced airway changes suggesting that this mediator is not per se responsible for airway remodelling [49] . These authors even warned against the use of therapeutic strategies aimed at interfering with TGF-␤ 1 .
The current study has some limitations. Firstly, for measuring airway responsiveness, we used the whole body plethysmograph, a method that has been criticised. There is evidence that Penh and airway resistance do not correlate under certain conditions, although plethysmography remains a valuable tool for explorative analysis [19, 50] . When Penh can be used as a surrogate for invasive measurements, it can decrease cost, time and the number of animals required for experiments. Secondly, in this study we could not provide in-depth explorations into the precise mechanisms that regulate the relationship between airway inflammation, remodelling and responsiveness. Although the limitations of this study should be taken into account, the current data provide researchers with clues to choose an appropriate asthma model for the particular aspects of the disease they want to investigate. There is currently no mouse model that completely mimics the pathology and physiology of patients with asthma.
In conclusion, genetic background has an impact on the different aspects of the acute allergic phenotype.
These differences are far less pronounced when studying chronic allergen exposure, albeit the latter models are characterized mainly by remodelling but not inflammation or AHR.
